Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$91.91 - $110.37 $6.99 Million - $8.4 Million
-76,073 Closed
0 $0
Q2 2021

Aug 10, 2021

SELL
$86.24 - $95.92 $2.06 Million - $2.3 Million
-23,927 Reduced 23.93%
76,073 $7.12 Million
Q1 2021

May 14, 2021

BUY
$71.83 - $95.48 $7.18 Million - $9.55 Million
100,000 New
100,000 $9.21 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Rovida Advisors Inc. Portfolio

Follow Rovida Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rovida Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rovida Advisors Inc. with notifications on news.